Skip to content
Open access

Mosaic TLR8 gain-of-function in an elderly female treated with JAK inhibitor and adjunctive therapy

Sep 2026 · Journal of human immunity · Vol 2 · 1 citation · 4 references
Medicine

TL;DR

An elderly woman with severe chronic neutropenia caused by mosaic TLR8 gain-of-function is described, which broadens a primarily pediatric, male disease spectrum and highlights somatic mosaicism as an important diagnostic consideration in adults with unexplained cytopenia and immune dysregulation.

Abstract

Patel et al. describe an elderly woman with severe chronic neutropenia caused by mosaic TLR8 gain-of-function. The report broadens a primarily pediatric, male disease spectrum and highlights somatic mosaicism as an important diagnostic consideration in adults with unexplained cytopenia and immune dysregulation.

Read PDF

Similar papers

Review Open access Oct 2026

TLR8 gain-of-function syndrome

In this Review, Gil and Cooper review the molecular, immunologic, and clinical features of TLR8 gain-of-function syndrome. They review findings from patients with mosaic and germline disease, and integrate knowledge of key structural components of the TLR8 protein.

Hwi M. Gil, M. Cooper · 0 citations
Open access Oct 2026

JAK-inhibitor treatment induces rapid yet incomplete immune reconstitution in STAT1 gain-of-function

Iglesias-Herrero et al. longitudinally assess JAK-inhibitor treatment response in two patients with STAT1 gain-of-function and show that it induces rapid but incomplete immune reconstitution, with increased TCR diversity and reversal of monocyte hyperinflammation, highlighting both therapeutic benefit and persistent im...

Cecilia Iglesias-Herrero, W. Roosens, G. Galicia et al. · 0 citations
Open access Oct 2026

Biallelic loss-of-function PTPN6 variants lead to inflammatory lung disease and hemolytic anemia

Moussavi-Harami et al. report that biallelic loss-of-function variants in PTPN6, encoding the immune-regulatory phosphatase SHP1, cause anemia and fatal lung hyperinflammation in families from diverse ethnic backgrounds.

S. Moussavi-Harami, M. Zinter, M. Motta et al. · 0 citations
Review Open access Sep 2026

Formulation and Systemic Therapy.

An 81-year-old woman receiving upadacitinib, a JAK-1 inhibitor, for rheumatoid arthritis developed herpes zoster ophthalmicus with significant ophthalmic morbidity and varicella-zoster virus encephalitis. Medication reconciliation revealed continued JAK-1 inhibition during early presentations. This case highlights the...

Taherah Khan, F. Moniati, Donna Thompson · 0 citations
Open access Sep 2026

Mycobacterium avium Complex Pulmonary Disease as a Clinical Signal of Host Vulnerability in Advanced Myelofibrosis

An 82‐year‐old woman with JAK2‐mutated myelofibrosis who developed hemoptysis after initiation of ruxolitinib. She presented with anemia and ground‐glass opacities and was treated with antibiotics. She was readmitted with worsening respiratory symptoms. Sputum cultures yielded Mycobacterium avium. Her clinical course w...

Mataichi Sekiya, Kalkidan Yekuno, Ishan Ghumare et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.